Point72 Hong Kong’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.11M Buy
+47,517
New +$2.32M 0.14% 113
2025
Q2
Sell
-12,862
Closed -$388K 590
2025
Q1
$388K Buy
+12,862
New +$421K 0.02% 267
2024
Q1
Sell
-20,015
Closed -$1.01M 666
2023
Q4
$1.01M Buy
+20,015
New +$959K 0.06% 275
2022
Q4
Sell
-3,740
Closed -$165K 852
2022
Q3
$165K Buy
+3,740
New +$158K 0.01% 1100
2022
Q2
Sell
-2,427
Closed -$90K 2153
2022
Q1
$90K Buy
2,427
+1,239
+104% +$40.6K ﹤0.01% 1182
2021
Q4
$36K Buy
+1,188
New +$37.4K ﹤0.01% 1423
2020
Q2
Sell
-791
Closed -$37K 1271
2020
Q1
$37K Sell
791
-3,138
-80% -$175K 0.02% 414
2019
Q4
$237K Buy
+3,929
New +$234K 0.06% 295
2019
Q2
Sell
-401
Closed -$33K 1252
2019
Q1
$33K Buy
+401
New +$25.9K 0.01% 605
2018
Q2
Sell
-2,498
Closed -$110K 1029
2018
Q1
$110K Buy
2,498
+1,796
+256% +$91.2K 0.06% 296
2017
Q4
$35K Buy
+702
New +$38.5K 0.03% 273
2016
Q3
Sell
-400
Closed -$9K 798
2016
Q2
$9K Buy
+400
New +$12.9K 0.01% 431
2016
Q1
Sell
-400
Closed -$25K 575
2015
Q4
$25K Buy
+400
New +$21.6K 0.08% 190

Other funds holding IONS

Point72 Hong Kong's IONS Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2025: 47,517 shares worth $3.11M. The stake represents 0.14% of the portfolio and ranks #113 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in IONS as recently as Q1 2025.

Point72 Hong Kong first reported a position in IONS in Q4 2015 and has held it in 13 quarters since. 436 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

  • Point72 Hong Kong held 47,517 shares of Ionis Pharmaceuticals worth $3.11M as of Q3 2025.
  • Ionis Pharmaceuticals was a new Point72 Hong Kong position in Q3 2025.
  • Ionis Pharmaceuticals made up 0.14% of Point72 Hong Kong's portfolio in Q3 2025, its #113 holding.
  • Point72 Hong Kong first reported a position in Ionis Pharmaceuticals in Q4 2015 and has held it in 13 quarters since.
  • 436 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.